Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Small-Cap Pharma Fast-Tracking Repurposed Drug for Covid-19

Algernon Pharmaceuticals is quickly moving ahead with a multinational Phase 2b/3 trial for Ifenprodil. Algernon Pharmaceuticals Inc. (AGN:CSE; AGNPF:OTCQB; AGW:FSE) , a Canada-based clinical stage drug development company that focuses on drug repurposing, believes ...
Streetwise Reports | May 28, 2020 |

Solving the Hemp Extraction Problem created by the US Farm Bill

A CONVERSATION WITH NICK KIMBALL, PRESIDENT AND CEO, CASCADIA EXTRACTS, and AARON WILLIAMS, EXECUTIVE VICE PRESIDENT, CASCADIA EXTRACTS MOTIVATION What was your motivation to enter the hemp market in 2019? KIMBALL : Two years ago, the cannabis market ...
Featured Submission | July 22, 2020 |

Software For Safe Medical Cannabis Access

Alternate Health’s integrated health services features clinical laboratories and CanaPass - online patient management software for safe access to medical cannabis. Currently generating revenue, Alternate Health plans to reinvest profit...
BTV-Business Television | June 9, 2018 |

Forging a New Path into the Medical Cannabis Space

Although 2019 was in many ways ‘The Year that the Cannabis Sector Would Like to Forget’, there are many pioneering ways that a company can take to generate revenue in the still-emerging medical cannabis and CBD markets. One such company has been advancing st...
Dave Jackson | February 13, 2020 |

Flying Under the Radar with a Possible COVID-19 Treatment

Investors would think a pharmaceutical company heading into Phase 2b/3 human trials for treating the third most malignant disease after lung cancer and pancreatic cancer would draw eyes from major players. If that same company announced it was embarking on Phase2b/3 human tri...
Stockhouse Editorial | September 8, 2020 |

XPhyto: The Cutting Edge of Medical Cannabis Science

At the forefront of the next wave of cannabis commercialization, is a German-focused company with headquarters in Vancouver, XPhyto Therapeutics Corp. (CSE: XPHY; FSE: 4XT) , that is building a much-coveted cannabis R&D cultivation facility in a converted nuclear bunker and o...
Marc Davis | May 14, 2020 |

Important Economic News Calendar: November 4 – November 8, 2019

The markets will likely take some breather in the coming week following last week’s huge economic data announcements. But that does not mean there won’t be trading opportunities coming from the data releases. Last week we asked if quarterly corp...
Paul Rejczak | November 4, 2019 |

Your One-stop-shop for All Things Plant-based is This Company

(Click image to play video) It’s no secret that the alternative meat and plant-based sector has gone through tremendous growth over the last several years as people shift away from animal-based products. Similarly, companies are also cap...
Jocelyn Aspa | May 4, 2021 |

MMT is a spectacularly Dem idea

Economists are good for one thing, and that is creating theories. The trouble is, those theories are often wrong. This is why economics is often called “the dismal science”. Such is the case with the latest economic soup-de-jour, Modern Monetary Theory, o...
Richard (Rick) Mills | April 12, 2019 |

This Canadian Biopharmaceutical Co. is a Pioneer of the Medical Cannabis Industry

An evidence-based, scientific approach is how Avicanna Inc. ( TSX.AVCN , OTC: AVCNF , Forum ) gains its competitive advantage in the medical cannabis sector. The Canadian biopharmaceutical company has spent over four years in research & development before creating its m...
Isabella Zavarise | December 22, 2020 |
1 2 3 4 5 6 7 8 9 10 ...